Patients with AIDS are at increased risk for opportunistic infections,
most notably Pneumocystis carinii pneumonia (PCP), cerebral toxoplasm
osis, Mycobacterium avium complex (MAC), cytomegalovirus (CMV) retinit
is, and cryptococcal meningitis, Trimethoprim plus sulfamethoxazole is
first-line therapy for both treatment and prophylaxis of PCP, and it
provides partial protection against cerebral toxoplasmosis, For treatm
ent of toxoplasmosis, pyrimethamine plus sulfadiazine is the top choic
e, Against MAC, clarithromycin combined with at least one other agent
(usually ethambutol) is recommended for treatment; rifabutin, clarithr
omycin, or azithromycin may be used for prophylaxis. Therapy for CMV r
etinitis focuses on using a ganciclovir-containing implant plus oral g
anciclovir, the top choice to prevent systemic CMV disease, For crypto
coccal meningitis, high-dose amphotericin B plus flucytosine is the mo
st effective initial treatment; fluconazole is useful for lifelong mai
ntenance therapy.